Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Rheumatology International|February 16, 2010
Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature reviewBradley J Bloom, Anthony J Alario, Laurie C Miller
The Journal of Rheumatology|April 13, 2002
Soluble adhesion molecules in pediatric rheumatic diseasesBradley J Bloom, Laurie C Miller, Peter R Blier
The Journal of Rheumatology|December 2, 2008
Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritisBradley J Bloom, Anthony J Alario, Laurie C Miller
Rheumatology International|December 14, 2006
Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesisBradley J Bloom, Mieko Toyoda, Anna Petrosian, et al.
The Journal of Rheumatology|February 5, 2005
Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritisBradley J Bloom, Sarah M Nelson, Daniel Eisenberg, et al.
The Journal of Rheumatology|February 5, 2002
Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritisBradley J Bloom, Judith A Owens, Melissa McGuinn, et al.
Journal of Clinical Pharmacology|September 1, 2011
Dosing celecoxib in pediatric patients with juvenile rheumatoid arthritisSriram Krishnaswami, Matt M Hutmacher, Jeffery L Robbins, et al.
Rheumatology International|September 7, 2002
Synovial fluid levels of E-selectin and intercellular adhesion molecule-1: relationship to joint inflammation in children with chronic arthritisBradley J Bloom, Sarah M Nelson, Anthony J Alario, et al.
The Journal of Rheumatology|March 3, 2012
Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexateThomas C Stock, Bradley J Bloom, Nathan Wei, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2006
Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot studyWilliam J Sandborn, William F Stenson, Jørn Brynskov, et al.
Pageof 2